App

WebMD seeks to unify health data

WebMD seeks to unify health data

By

The health and lifestyle resource's latest app seeks to provide context for all that biometric data consumers are storing in wearables, wireless scales and glucometers.

Everyday Health rolls out CancerRx app

Everyday Health rolls out CancerRx app

By

The bedside decision-making app includes clinical trial and drug information as well as breaking news.

App can estimate blood loss

The maker of an FDA-approved app says its algorithm can use images to assess surgery-related blood loss.

Startup clinical trial app

TapTrak seeks to apply behavioral tracking to clinical trials.

FDA exempts most mobile apps from scrutiny

FDA exempts most mobile apps from scrutiny

By

The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don't work correctly.

Business briefs: Biosimilars, Johnson & Johnson, Consumer Reports

FDA is concerned state biosimilar legislation could make consumers uneasy about the category, J&J hands $75 million milestone payment for ibrutinib, Consumer Reports gets into drug apps

A Parkinson's app for patients that took its cue from HCPs

A Parkinson's app for patients that took its cue from HCPs

By

Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.

Omnio app fuses research, social and office capabilities

Omnio app fuses research, social and office capabilities

By

The months-old app seeks to become an all-in-one HCP tool and work on a 3.0 version is already in place.

Business briefs: Medscape, Livestrong, ACA, Lilly

Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results

Business briefs: Teva, Celgene, Komen, Apple, OPDP

Plan B age limits retained and rejected, Celgene drugs gets expanded indication, Komen cuts back on walks, Apple is policing medical apps, OPDP director's Q&A

Business briefs: Sanofi; Doximity; NYBA

Sanofi named Connect & Coach as the winner of its 2013 Data Design Diabetes contest

Business briefs: Actavis, Bayer, Oramed, Elan

Actavis buys Warner Chilcott, FDA clears oral insulin for testing, Elan swallows AOP Orphan for $340M

Business briefs: Bayer, FDA, Ranbaxy

Bayer's prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations

Business briefs: PwC, Novartis, iDoc24, FDA

PricewaterhouseCoopers says consumers are talking healthcare, but not about the good stuff; Novartis shuffles 120 Texas jobs; 73% of STD app queries came from men last month; FDA is keeping very busy; and OgilvyCommonhealth hires a consumer head

Business briefs: Roche, Vital Art and Science, Gilead, Sanofi

Roche and Isis pair up for Huntingtons, Vital's prescription vision app gets approved, FDA approval revives maligned morning sickness drug, Gilead sends hep C therapy to regulators and Sanofi's emerging market exposure grabs attention.

Shazam! Sanofi Pasteur strikes a chord with Fluzone audience

Shazam! Sanofi Pasteur strikes a chord with Fluzone audience

By

Sanofi Pasteur scored a pharma first this past winter by offering "Shazam" technology as a way for viewers to interact with TV commercials for its Fluzone Intradermal influenza vaccine—and to find out where they could get the new shot.

Business briefs: Shire, AthenaHealth, GSK, Novartis

Shire expands its pipeline yet again, AthenaHealth stretches its HCP-patient reach, FDA delays GSK's bird-flu vaccine, Novartis wins approval for cystic fibrosis inhaler

Shire launches ADHD tech challenge

By

Taking a page from Sanofi, Shire is preparing to launch a developer challenge "to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood."

Company news: GlaxoSmithKline, Royal Philips

GSK, Pfizer and Shionogi's HIV medication to get its day in regulatory court; Philips finds that mobile and health are becoming inseparable.

Company news: Nature Publishing Group, Elsevier, Medicare

Nature releases the Antibodypedia's seventh generation, Elsevier adds more board review apps, and how redefining "senior" may not save money in the long run

Company news: Novo Nordisk

Novo Nordisk has launched a hemophilia app; and a report says the Chinese OTC market is going gangbusters

Company news: Sanofi, Haymarket

Sanofi's new chief medical officer takes a seat Jan. 1, Clinical Advisor launches a new app.

Company news: Sudler & Hennessey, Merck, WebMD and Fitbit

Sudler exec snags a lifetime Clio award, Merck leaves ALEC, and WebMD launches a pain app.

Company news: Lilly, Merck KGaA

Lilly releases a diabetes app for caregivers, Merck KGaA to slash close to 1,100 jobs.

New ad model fosters pharma's leap to digital, publisher finds

New ad model fosters pharma's leap to digital, publisher finds

By

Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.

Company news: Chelsea Therapeutics, iHealth

Chelsea Therapeutics clears house, trims focus; FDA grants 501 (k) status to a bluetooth blood pressure monitor.

Company news: Novo Nordisk and Health Union

Company news: Novo Nordisk and Health Union

Novo Nordisk expanded its motorsports initiative, while online firm Health Union launched a mobile app designed to help patients monitor migraines.

Nurses get their own app with Lippincott launch

Nurses get their own app with Lippincott launch

By

As of Monday, nurses will be able to tap into the Nursing Drug Handbook with an app, a first for the 32-year-old publication.

Company news: WebMD, Wiley-Blackwell and Eli Lilly/Boehringer Ingelheim

WebMD the Magazine is now part of the iPad app world.

Sanofi contest gooses diabetes tech innovation

Sanofi contest gooses diabetes tech innovation

By

Sanofi is re-upping its social media-driven Data Design Diabetes Innovation Challenge contest, which last year kicked up a wealth of innovative ideas and buzz for the price of $200,000 in prize money and a few salaries.

Email Newsletters